Patents by Inventor Anne Gauvrit

Anne Gauvrit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9636395
    Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: May 2, 2017
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Anne Gauvrit, Frédéric Tangy, Marc Gregoire
  • Publication number: 20150209423
    Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.
    Type: Application
    Filed: April 8, 2015
    Publication date: July 30, 2015
    Inventors: Anne Gauvrit, Frédéric Tangy, Marc Gregoire
  • Patent number: 9023643
    Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.
    Type: Grant
    Filed: October 10, 2008
    Date of Patent: May 5, 2015
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique
    Inventors: Anne Gauvrit, Frédéric Tangy, Marc Gregoire
  • Publication number: 20100278872
    Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.
    Type: Application
    Filed: October 10, 2008
    Publication date: November 4, 2010
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCH MEDICALE (INSERM), INSTITUT PASTEUR
    Inventors: Anne Gauvrit, Frédéric Tangy, Marc Gregoire